Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

J. de Nooy-van Tol, M. Koopman, A. Cats, C.J. Rodenburg, G.J.M. Creemers, J.G. Schrama, F.L.G. Erdkamp, A.H. Vos, C.J. van Groeningen, H.A.M. Sinnige, D.J. Richel, E.E. Voest, J.R. Dijkstra, M.E. Vink-Borger, N.F. Antonini, L. Mol, J.H.J.M. van Krieken, O. Dalesio, C.J.A. Punt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)563-572
JournalNew England Journal of Medicine
Volume360
Issue number6
DOIs
Publication statusPublished - 2009

Cite this

de Nooy-van Tol, J., Koopman, M., Cats, A., Rodenburg, C. J., Creemers, G. J. M., Schrama, J. G., ... Punt, C. J. A. (2009). Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer. New England Journal of Medicine, 360(6), 563-572. https://doi.org/10.1056/NEJMoa0808268